1015076-83-1

Basic information

• Product Name: sodium 2-[3-(3-bromo-phenyl)-3-oxo-propenyl]-benzoate
• Synonyms: sodium 2-[3-(3-bromo-phenyl)-3-oxo-propenyl]-benzoate
• CAS NO: 1015076-83-1
• Molecular Weight: 353.147
• Mol File: 1015076-83-1.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: sodium 2-[3-(3-bromo-phenyl)-3-oxo-propenyl]-benzoate(CAS DataBase Reference)
• NIST Chemistry Reference: sodium 2-[3-(3-bromo-phenyl)-3-oxo-propenyl]-benzoate(1015076-83-1)
• EPA Substance Registry System: sodium 2-[3-(3-bromo-phenyl)-3-oxo-propenyl]-benzoate(1015076-83-1)

Safety Data

• Hazardous Substances Data: 1015076-83-1(Hazardous Substances Data)

Upstream product

• 16859-59-9 3-hydroxy-1(3H)-isobenzofuranone 
• 2142-63-4 1-(3-Bromophenyl)ethanone 
• 119-67-5 o-carboxybenzaldehyde 

Downstream Products

• 165896-48-0 2-[3-(3-bromo-phenyl)-3-oxo-propyl]-benzoic acid methyl ester 
• 287930-77-2 (S,E)-1-(3-(2-(7-chloroquinolin-2-yl)vinyl)phenyl)-3-(2-(2-hydroxypropan-2-yl)phenyl)propan-1-ol 
• 181139-72-0 methyl-[(E)]-2-[3(S)-[3-[2-(7-chloro-2-quinolinyl)ethenyl]phenyl]-3-hydroxypropyl] benzoate 

Relevant articles and documents

SYNTHESIS OF LEUKOTRIENE COMPOUNDS

The present invention relates to the synthesis of leukotriene receptor agonist compounds and to novel intermediates employed in their preparation. Leukotriene agonists are used in the treatment of asthma, as well as other conditions mediated by leukotrienes such as inflammation and allergies. A compound of particular interest is montelukast and the present invention describes an improved process for making montelukast and similar compounds.